[Vitamin D: influence of anticonvulsant drugs on its metabolism].
D000818:Animals; D000927:Anticonvulsants / Q000009:adverse effects*; D004100:Dihydroxycholecalciferols / Q000378:metabolism; D006801:Humans; D006887:Hydroxycholecalciferols / Q000378:metabolism; D006900:Hydroxylation; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D010634:Phenobarbital / Q000009:adverse effects / Q000627:therapeutic use; D010672:Phenytoin / Q000009:adverse effects / Q000627:therapeutic use; D011324:Primidone / Q000009:adverse effects / Q000627:therapeutic use; D014807:Vitamin D / Q000378:metabolism*; D014808:Vitamin D Deficiency / Q000209:etiology
D000927:Anticonvulsants; D004100:Dihydroxycholecalciferols; D006887:Hydroxycholecalciferols; D011324:Primidone; D014807:Vitamin D; D010672:Phenytoin; D010634:Phenobarbital
La vitamine D: influence des médicaments anticonvulsivants sur son métabolisme